跳至主要内容
临床试验/ISRCTN19517317
ISRCTN19517317已完成未知

A randomised controlled feasibility Trial of Intraoperative Cell salvage vs donor blood Transfusion in Ovarian Cancer surgery (TICTOC)

Royal Cornwall Hospitals NHS Trust0 个研究点目标入组 57 人开始时间: 2016年11月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
57

研究概览

简要总结

2018 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/30389760 protocol (added 01/11/2019)

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. 18 years old or over
  • 2. Suspected or confirmed ovarian cancer (newly diagnosed) requiring cytoreductive surgery, whether primary or interval (following chemotherapy)
  • 3. CT scan evidence (with or without clinical evidence) compatible with FIGO stage III/IV ovarian cancer/ primary peritoneal cancer at presentation*
  • 4. ECOG Performance Status 0-1
  • 5. Willing to participate and able to give written informed consent
  • *CT features of pelvic mass (or features suggestive of primary peritoneal cancer) and extrapelvic involvement including ascites, omental disease, peritoneal thickening, bowel surface and/or mesentery involvement, enlarged pelvic and para-aortic lymph nodes, evidence of disease on diaphragm

排除标准

  • 1. Diagnosis of concurrent malignancy
  • 2. Pregnant
  • 3. Donor transfusion during the week prior to surgery
  • 4. Haemoglobinopathies (e.g. sickle cell, thalassaemia)
  • 5. Unwilling to accept donor blood (e.g. on religious grounds)

研究者

相似试验